Pfizer’s Covid product sales to top $50 bln this year, investors want more

Pfizer currently expects $22 billion in 2022 sales of the treatment, compared with Wall Street estimates of $22.88 billion.

Leave a Reply

Your email address will not be published. Required fields are marked *